Skip to Content

Mycobutin

In the US, Mycobutin (rifabutin systemic) is a member of the drug class rifamycin derivatives and is used to treat Mycobacterium avium-intracellulare - Prophylaxis, Mycobacterium avium-intracellulare - Treatment, Tuberculosis - HIV Positive and Tuberculosis - Prophylaxis.

US matches:

UK matches:

Ingredient matches for Mycobutin

Rifabutin

Rifabutin is reported as an ingredient of Mycobutin in the following countries:

  • Australia
  • Austria
  • Belgium
  • Canada
  • Czech Republic
  • Hong Kong
  • Ireland
  • Israel
  • Italy
  • Japan
  • Netherlands
  • New Zealand
  • Portugal
  • South Africa
  • Switzerland
  • Taiwan
  • Turkey
  • United Kingdom
  • United States

International Drug Name Search

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide